SignatureFD’s 2seventy bio TSVT Stock Holding History

SignatureFD’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-169	Closed	-$1.71K	–	3307
2023 Q2	$1.71K	Buy	169 +142	+526%	+$1.5K	﹤0.01%	2856
2023 Q1	$275	Buy	+27	New	+$309	﹤0.01%	3160

Other funds holding TSVT

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

SignatureFD's TSVT Position: Q3 2023 in Review

SignatureFD sold out of 2seventy bio (TSVT) in Q3 2023, closing a stake of 169 shares — an estimated $1.71K sold.

SignatureFD first reported a position in TSVT in Q1 2023 and held it in 2 quarters. The position peaked at $1.71K in Q2 2023. 145 funds tracked by Wall St. Rank hold TSVT as of Q3 2023.

SignatureFD reported no remaining 2seventy bio position as of Q3 2023 after selling out during the quarter.
SignatureFD sold 169 2seventy bio shares in Q3 2023, an estimated $1.71K.
SignatureFD first reported a position in 2seventy bio in Q1 2023 and held it in 2 quarters.
SignatureFD's 2seventy bio position peaked at $1.71K in Q2 2023.
145 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2023.

Based on SignatureFD's 13F filing for Q3 2023, filed 3 Nov 2023.